The European Medicines Agency (EMA) has advised that the drug can be used together with diet and physical activity to help ...
US pharma giants eye India’s obesity crisis with pricey shots, sparking ‘Make in India’ and affordability debates ...
US giant, Eli Lilly launched Mounjaro (tirzepatide) which is a prescription medicine for adults with type 2 diabetes used ...
Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
A new study has found that a once-weekly injection of semaglutide, a medication originally developed for diabetes and weight ...
The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...
Rajya Sabha member Milind Deora has criticised the launch of Mounjaro in India. The weight-loss drug, developed by US-based ...
Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.
Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...
Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken ...
Eli Lilly Latest News and Updates, Special Reports, Videos & Photos of Eli Lilly on India TV. Articles on Eli Lilly, Complete Coverage on Eli Lilly ...